Trastuzumab is a recombinant IgG1 monoclonal antibody. It works against the HER2 (human epidermal growth factor receptor protein) receptors which are responsible for the over-proliferation of cancer cells in breast cancer and stomach cancer cells. It destroys the cancer cells by inhibiting HER2. It also inhibits various cancer-causing downstream signaling pathways.
Common side effects of Trastuzumab
Chills, Diarrhea, Fever, Headache, Nausea, Back pain, Vomiting, Weakness, Breathlessness